An initial fall and lasting control are different
Some emergency treatments move potassium into cells, while other approaches remove potassium from the body. This helps explain why another measurement may be required after the first result improves. The possibility of a rise again depends on kidney function and the treatments used. [1]
Timing repeat blood tests
The initial level, speed of change, other illnesses and new treatments influence the timing of review. One interval cannot be recommended for everyone. Before leaving hospital or a clinic, clarify when blood should be taken, who will review the result and how it will be communicated. A test without a clear review arrangement leaves an important part of follow-up unresolved. [1]
Keeping the medicine list current
Medicines may have been changed, paused or restarted. The current plan should be distinguished from an old prescription list. Maintaining treatments that benefit the heart and kidneys also matters, so decisions are made by the clinician using blood results and the person’s wider condition. [2]
Include non-prescription pain medicines, vitamin and mineral products and herbal supplements. A pharmacist can help bring treatments from different services into a single accurate list and identify questions for the prescribing team.
Changes to report
New vomiting or diarrhoea, substantial changes in food intake, salt-substitute use and other illnesses may be relevant. People with kidney disease may benefit from an individual plan for illness days. Medicines and fluid intake should not be changed arbitrarily without such a plan. [2, 3]
When an earlier assessment is needed
New palpitations, fainting or marked muscle weakness warrant urgent assessment rather than waiting for the next appointment. Instructions about a critical blood result should be followed even without symptoms. Follow-up is more than checking a number: it also identifies changes that could allow potassium to rise again and establishes how to respond before the next routine visit. [1]
References
- UKKA: Management of hyperkalaemia in adults, updated July 2026
- KDIGO 2024 CKD Guideline
- NIDDK: Keeping kidneys safe
This article provides general health information. Consult your clinician for individual diagnosis and treatment decisions, and your pharmacist for questions about medicine use.
Published by Aymed İlaç · 17 October 2026
